These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1027 related articles for article (PubMed ID: 32764874)
1. Network Pharmacology-Based Prediction and Verification of the Active Ingredients and Potential Targets of Zuojinwan for Treating Colorectal Cancer. Huang S; Zhang Z; Li W; Kong F; Yi P; Huang J; Mao D; Peng W; Zhang S Drug Des Devel Ther; 2020; 14():2725-2740. PubMed ID: 32764874 [TBL] [Abstract][Full Text] [Related]
2. A Network Pharmacology Analysis of the Active Components of the Traditional Chinese Medicine Zuojinwan in Patients with Gastric Cancer. Zhang Z; Li B; Huang J; Huang S; He D; Peng W; Zhang S Med Sci Monit; 2020 Aug; 26():e923327. PubMed ID: 32866138 [TBL] [Abstract][Full Text] [Related]
3. Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis. Liu J; Liu J; Tong X; Peng W; Wei S; Sun T; Wang Y; Zhang B; Li W Drug Des Devel Ther; 2021; 15():3255-3276. PubMed ID: 34349502 [TBL] [Abstract][Full Text] [Related]
4. Research on the Regulatory Mechanism of Ginseng on the Tumor Microenvironment of Colorectal Cancer based on Network Pharmacology and Bioinformatics Validation. Wang T; Zhang W; Fang C; Wang N; Zhuang Y; Gao S Curr Comput Aided Drug Des; 2024; 20(5):486-500. PubMed ID: 37287284 [TBL] [Abstract][Full Text] [Related]
5. Understanding apoptotic induction by Sargentodoxa cuneata-Patrinia villosa herb pair via PI3K/AKT/mTOR signalling in colorectal cancer cells using network pharmacology and cellular studies. Mu BX; Li Y; Ye N; Liu S; Zou X; Qian J; Wu C; Zhuang Y; Chen M; Zhou JY J Ethnopharmacol; 2024 Jan; 319(Pt 3):117342. PubMed ID: 37879505 [TBL] [Abstract][Full Text] [Related]
6. A network pharmacology-based investigation on the bioactive ingredients and molecular mechanisms of Gelsemium elegans Benth against colorectal cancer. Que W; Chen M; Yang L; Zhang B; Zhao Z; Liu M; Cheng Y; Qiu H BMC Complement Med Ther; 2021 Mar; 21(1):99. PubMed ID: 33743701 [TBL] [Abstract][Full Text] [Related]
7. Research on the Potential Mechanism of Gentiopicroside Against Gastric Cancer Based on Network Pharmacology. Huang Y; Lin J; Yi W; Liu Q; Cao L; Yan Y; Fu A; Huang T; Lyu Y; Huang Q; Wang J Drug Des Devel Ther; 2020; 14():5109-5118. PubMed ID: 33262572 [TBL] [Abstract][Full Text] [Related]
8. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway. Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation. Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B Front Immunol; 2023; 14():1235575. PubMed ID: 37799727 [TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of Huanglian Jiedu decoction in treating Alzheimer's disease by regulating microbiome Zheng R; Shi S; Zhang Q; Yuan S; Guo T; Guo J; Jiang P Front Cell Infect Microbiol; 2023; 13():1140945. PubMed ID: 37009506 [TBL] [Abstract][Full Text] [Related]
11. Network pharmacology-based prediction and verification of the active ingredients and potential targets of Huagan Decoction for reflux esophagitis. Zhao Y; Cao Y; Yang X; Guo M; Wang C; Zhang Z; Zhang Q; Huang X; Sun M; Xi C; Tangthianchaichana J; Bai J; Du S; Lu Y J Ethnopharmacol; 2022 Nov; 298():115629. PubMed ID: 35988839 [TBL] [Abstract][Full Text] [Related]
12. Network-Pharmacology-Based Study on Active Phytochemicals and Molecular Mechanism of Cnidii Fructus in Treating Colorectal Cancer. Wei Z; Zhang X; Peng A; Liu C; Pang J; Zhang Y; Duan X Comb Chem High Throughput Screen; 2024; 27(18):2667-2680. PubMed ID: 37861043 [TBL] [Abstract][Full Text] [Related]
13. Exploring the mechanism of Erteng-Sanjie capsule in treating gastric and colorectal cancers via network pharmacology and in-vivo validation. Zhang W; Wang Y; Yu H; Jin Z; Yuan Y; Liu L; Zhou J J Ethnopharmacol; 2024 Jun; 327():117945. PubMed ID: 38428659 [TBL] [Abstract][Full Text] [Related]
14. [Mechanism of Huachansu Injection against colorectal cancer based on network pharmacology and cellular experimental]. Meng ZY; Zhao J; Zhu QF; Xiang DF; Meng JJ; Chen JJ; Jiang B; Hu YJ; Xu LY; Zhang XQ; Zou H; Han YL Zhongguo Zhong Yao Za Zhi; 2024 Sep; 49(17):4755-4767. PubMed ID: 39307810 [TBL] [Abstract][Full Text] [Related]
15. Network pharmacology and experimental verification study on the mechanism of Hedyotis diffusa Willd in treating colorectal cancer. Yuan X; Huang H; Yu C; Tang Z; Li Y Naunyn Schmiedebergs Arch Pharmacol; 2024 Sep; 397(9):6507-6521. PubMed ID: 38446216 [TBL] [Abstract][Full Text] [Related]
16. Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke. Zhao S; Zhang P; Yan Y; Xu W; Li J; Wang L; Wang N; Huang Y J Ethnopharmacol; 2023 Aug; 312():116507. PubMed ID: 37080367 [TBL] [Abstract][Full Text] [Related]
17. Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation. Zhang Z; Liu J; Liu Y; Shi D; He Y; Zhao P J Ethnopharmacol; 2021 Apr; 269():113696. PubMed ID: 33358854 [TBL] [Abstract][Full Text] [Related]
18. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking. Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376 [TBL] [Abstract][Full Text] [Related]
19. Network Pharmacology-Based Strategy Combined with Molecular Docking and in vitro Validation Study to Explore the Underlying Mechanism of Huo Luo Xiao Ling Dan in Treating Atherosclerosis. Sun T; Quan W; Peng S; Yang D; Liu J; He C; Chen Y; Hu B; Tuo Q Drug Des Devel Ther; 2022; 16():1621-1645. PubMed ID: 35669282 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Mechanism of Yishan Formula in Treating Breast Cancer Based on Network Pharmacology and Experimental Verification. Lin X; Chi W; Geng X; Jiang Q; Ma B; Dai B; Sui Y; Jiang J Comb Chem High Throughput Screen; 2024; 27(17):2583-2597. PubMed ID: 38178684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]